BioCer HaemoCer™ Haemostatic Powder

Land: Singapur

Sprache: Englisch

Quelle: HSA (Health Sciences Authority)

Verfügbar ab:

NOVEM HEALTHCARE PTE LTD

Klasse:

Class D medical device

Hergestellt von:

BioCer Entwicklungs-GmbH

Therapiebereich:

General & Plastic Surgery

Anwendungsgebiete:

HaemoCer™ is an adjunct hemostatic agent for use in surgical procedures, when control of bleeding from capillary, venous, or arteriolar vessels by pressure, ligature and other conventional procedures is either ineffective or impractical.

Produktbesonderheiten:

Device System Info:[System or Procedure Pack], [Sterile Medical Device], Radiation sterilisation for the haemostatic powder and EO sterilization for the applicator; Models: HaemoCer™ Haemostatic Powder (5g) - HFP105, HaemoCer™ Haemostatic Powder (2g) - HFP102, HaemoCer™ PLUS Haemostatic Powder 1g powder with applicator - HFP201, HaemoCer™ PLUS Haemostatic Powder 2g powder with applicator - HFP202, HaemoCer™ PLUS Haemostatic Powder 3g powder with applicator - HFP203, HaemoCer™ PLUS Haemostatic Powder 5g powder with applicator - HFP205, HaemoCer™ Universal Applicator - HFZ101

Berechtigungsdatum:

2013-05-23